Artiva Biotherapeutics, Inc. · NASDAQ:ARTV

Aslan Fred sold 23,463 Artiva Biotherapeutics, Inc. shares (Form 4)

Traded Oct 6, 2026 · Filed Oct 7, 2026

On Oct 6, 2026, Aslan Fred (Director, Chief Executive Officer) sold 23,463 Artiva Biotherapeutics, Inc. shares at US$7.20 for US$169K under a trading plan, leaving 1,519,606 shares. Filed Oct 7, 2026 (Form 4).

Sold
23,463 shares
Price
US$7.20
Value
US$169K
Holding after
1,519,606 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 6, 2026Common StockSale23,463US$7.201,519,606Direct

Source

View original at SEC

Related